October 8, 2024 12:00 PM EDT

Compounding pharmacy group sues FDA for ending Eli Lilly's GLP-1 drug shortage

Shelby Livingston

Health tech correspondent

A trade group for large compounding pharmacies sued the FDA over its move to take Eli Lilly’s blockbuster GLP-1 drug off its shortage list, hamstringing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Compounding pharmacy group sues FDA for ending Eli Lilly's GLP-1 drug shortage

Shelby Livingston

Health tech correspondent

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Trump asks 'very tough hombre' Dr. Oz to lead MFN talks

US warns drugmakers against misrepresenting cost of imported products

Endpoints 100 biotech survey: Welcome to the summer of biotech’s discontent

About 5% of CBER and CDER left after FDA staff cuts, analysis finds

Big leases, bigger regrets: Biotech slump turns swanky offices from asset into liability

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?

Com­pound­ing phar­ma­cy group sues FDA for end­ing Eli Lil­ly's GLP-1 drug short­age

Health tech correspondent

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Compounding pharmacy group sues FDA for ending Eli Lilly's GLP-1 drug shortage